Self-administration of Subcutaneous Elranatamab in the Patients' Homes.

Clinical trial NCT06015542 · RECRUITING

Trial details

NCT number: NCT06015542
Sponsor: Thomas Lund
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2025-01-29
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.